296 related articles for article (PubMed ID: 35352634)
1. Long-Term Outcomes of Living Donor Versus Deceased Donor Liver Transplant for Hepatocellular Carcinoma in the United States.
Muhammad H; Gurakar M; Ting PS; Alsughayer AM; Luu H; Zaffar D; Alqahtani S; Bonder A; Gurakar A; Saberi B
Exp Clin Transplant; 2022 Mar; 20(3):279-284. PubMed ID: 35352634
[TBL] [Abstract][Full Text] [Related]
2. OPTN/SRTR 2022 Annual Data Report: Liver.
Kwong AJ; Kim WR; Lake JR; Schladt DP; Schnellinger EM; Gauntt K; McDermott M; Weiss S; Handarova DK; Snyder JJ; Israni AK
Am J Transplant; 2024 Feb; 24(2S1):S176-S265. PubMed ID: 38431359
[TBL] [Abstract][Full Text] [Related]
3. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
4. Lessons Learned From Review of a Single Center Experience With 500 Consecutive Liver Transplants in a Region With Insufficient Deceased-Donor Support.
Yankol Y; Mecit N; Kanmaz T; Cimsit B; Cakaloglu Y; Acarli K; Kalayoglu M
Exp Clin Transplant; 2016 Apr; 14(2):191-200. PubMed ID: 26030810
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.
Yosry A; Abdel-Rahman M; Esmat G; El-Serafy M; Omar A; Doss W; Zayed N; Said M; Ismail T; Hosny A; Marawan E; El-Malt O; Kamel RR; Hatata Y; El-Taweel A; Ghali A; Sabri H; Kamel S; El-Gabaly H
Exp Clin Transplant; 2009 Sep; 7(3):157-63. PubMed ID: 19715525
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Risk Factor of Hepatocellular Carcinoma Recurrence After Liver Transplant: Results From a Single Clinic.
Bolkvadze R; Kashibadze K; Nakashidze M; Mikeladze L; Beridze D; Beridze S
Exp Clin Transplant; 2024 Jan; 22(Suppl 1):256-262. PubMed ID: 38385408
[TBL] [Abstract][Full Text] [Related]
8. Impact of Median MELD at Transplant Minus 3 National Policy on Quality of Transplanted Livers for Patients With and Without Hepatocellular Carcinoma.
Mazur RD; Cron DC; Chang DC; Yeh H; Dageforde LAD
Transplantation; 2024 Jan; 108(1):204-214. PubMed ID: 37189232
[TBL] [Abstract][Full Text] [Related]
9. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States.
Russo MW; Galanko J; Beavers K; Fried MW; Shrestha R
Liver Transpl; 2004 Mar; 10(3):340-6. PubMed ID: 15004758
[TBL] [Abstract][Full Text] [Related]
10. Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death.
Nakamura T; Sasaki K; Kojima L; Teo R; Inaba Y; Yamamoto T; Kimura S; Dageforde LA; Yeh H; Elias N; Bozorgzadeh A; Kawai T; Markmann JF
Clin Transplant; 2023 Aug; 37(8):e14989. PubMed ID: 37039506
[TBL] [Abstract][Full Text] [Related]
11. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
[TBL] [Abstract][Full Text] [Related]
12. Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
Silverstein J; Roll G; Dodge JL; Grab JD; Yao FY; Mehta N
Liver Transpl; 2020 Sep; 26(9):1100-1111. PubMed ID: 32531867
[TBL] [Abstract][Full Text] [Related]
13. Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria.
Alim A; Erdogan Y; Dayangac M; Yuzer Y; Tokat Y; Oezcelik A
Cancer Control; 2021; 28():10732748211011960. PubMed ID: 33926242
[TBL] [Abstract][Full Text] [Related]
14. Would a 6-Month Wait Time for Patients With Hepatocellular Carcinoma Improve Organ Allocation in Centers With Active Living Related Liver Transplant Activity?
Shaheen MF; Alomar A; Alrasheed M; Aldokhel F; Alsaleh A; Alghamdi H; O'hali W; Bin Saad K
Exp Clin Transplant; 2023 Feb; 21(2):132-138. PubMed ID: 36919721
[TBL] [Abstract][Full Text] [Related]
15. Survival Benefit of Living-Donor Liver Transplant.
Jackson WE; Malamon JS; Kaplan B; Saben JL; Schold JD; Pomposelli JJ; Pomfret EA
JAMA Surg; 2022 Oct; 157(10):926-932. PubMed ID: 35921119
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Wait-List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant Candidates.
Ziogas IA; Hickman LA; Matsuoka LK; Izzy M; Montenovo MI; Rega SA; Feurer ID; Alexopoulos SP
Liver Transpl; 2020 Sep; 26(9):1112-1120. PubMed ID: 32475062
[TBL] [Abstract][Full Text] [Related]
17. Deceased-donor split-liver transplantation in adult recipients: is the learning curve over?
Cauley RP; Vakili K; Fullington N; Potanos K; Graham DA; Finkelstein JA; Kim HB
J Am Coll Surg; 2013 Oct; 217(4):672-684.e1. PubMed ID: 23978530
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network.
Smith CM; Davies DB; McBride MA
Clin Transpl; 2000; ():19-30. PubMed ID: 11512312
[TBL] [Abstract][Full Text] [Related]
19. OPTN/SRTR 2021 Annual Data Report: Liver.
Kwong AJ; Ebel NH; Kim WR; Lake JR; Smith JM; Schladt DP; Schnellinger EM; Handarova D; Weiss S; Cafarella M; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2023 Feb; 23(2 Suppl 1):S178-S263. PubMed ID: 37132348
[TBL] [Abstract][Full Text] [Related]
20. The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C.
Pang PS; Kamal A; Glenn JS
Liver Transpl; 2009 Sep; 15(9):1126-32. PubMed ID: 19718638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]